com tam
Selected indexed studies
- Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization. (Cancer Cell, 2024) [PMID:38640932]
- LINC00330/CCL2 axis-mediated ESCC TAM reprogramming affects tumor progression. (Cell Mol Biol Lett, 2024) [PMID:38769475]
- GPR65 sensing tumor-derived lactate induces HMGB1 release from TAM via the cAMP/PKA/CREB pathway to promote glioma progression. (J Exp Clin Cancer Res, 2024) [PMID:38576043]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization. (2024) pubmed
- LINC00330/CCL2 axis-mediated ESCC TAM reprogramming affects tumor progression. (2024) pubmed
- GPR65 sensing tumor-derived lactate induces HMGB1 release from TAM via the cAMP/PKA/CREB pathway to promote glioma progression. (2024) pubmed
- Tamoxifen retinopathy. (2023) pubmed
- RelB-activated GPX4 inhibits ferroptosis and confers tamoxifen resistance in breast cancer. (2023) pubmed
- Targeting lipid metabolism of macrophages: A new strategy for tumor therapy. (2025) pubmed
- Bill. (2022) pubmed
- Single-cell transcriptional atlas of tumor-associated macrophages in breast cancer. (2024) pubmed
- Serotonin-licensed macrophages potentiate chemoresistance via inositol metabolic crosstalk in ovarian cancer. (2026) pubmed
- Cancer-associated fibroblast-secreted IGFBP7 promotes gastric cancer by enhancing tumor associated macrophage infiltration via FGF2/FGFR1/PI3K/AKT axis. (2023) pubmed